Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
20
datasets available to search
ShareScore release 0.9.0
Dataset results
20 results for “Policosanol”
Efficacy and Safety Study of Policosanol
ClinicalTrials.gov study NCT02543099. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Policosanol extraction patents: prospecting in database SciFinder
<p>This patent prospecting report was generated as part of an academic research carried out in the Doctoral Program in Industrial Engineering at the Federal University of Bahia (PEI-UFBA); include abstract, concepts, substances, formulations, analytical methods, and citations. Initially found 32 documents, of which 28 were selected for adherence to the scope of the substance and methods of preparation. The original format of the report generated by the database was preserved. </p>
Policosanol extraction patents in six extraction routes from IP Business Intelligence of Orbit seekers (version 1.9.8)®: World and Ibero-American countries (PDF Format).
<p>These results include tables of contents in PDF format of patents, corresponding to the substance Policosanol and its six main extraction methods, in the world and in Ibero-American countries, prospected from Advanced Search and IP Business Intelligence of Orbit seekers (version 1.9.8)<sup>® </sup>(Orbit, 2013, 2015; Orbit Intelligence, 2021, 2022; Winson, 2013).</p> <p>No results were found for the Ibero-American countries, in technological route 5 - "Molecular Distillation", until June 29, 2024, reason for the absence of their respective files in PDF and CSV.</p> <p>The prospecting reports contain the following information:</p> <ol> <li>Priority numbers</li> <li>Application number</li> <li>Publication numbers</li> <li>Family numbers</li> <li>Priority dates</li> <li>Application dates</li> <li>Publication dates</li> <li>Grant date</li> <li>Expected expiry dates</li> <li>Titles</li> <li>Abstracts</li> <li>Assignees</li> <li>Inventors</li> <li>Representatives</li> <li>Key content</li> <li>Technical concepts</li> <li>Images</li> <li>Claims</li> <li>Description</li> <li>Keywords in context</li> <li>Technology domains</li> <li>Cooperative classification</li> <li>International classification</li> <li>US patent classification</li> <li>Japanese classifications</li> <li>Citing patents (forward citations)</li> <li>Citing patents - Raw information</li> <li>Cited patents (backward citations)</li> <li>Cited patents - Raw information</li> <li>Cited non-patent literature</li> <li>Legal status</li> <li>Legal actions</li> <li>Designated states</li> <li>Protected authorities</li> <li>Farliest countries</li> <li>Assignee country</li> <li>Representative country</li> <li>Inventor country</li> <li>Cited patents (backward citations) - Counts</li> <li>Citing patents (forward citations) - Counts</li> <li>Independent claims - Counts</li> <li>Dependent claims - Counts</li> <li>All claims - Counts</li> <li>Assignees - Counts</li> <li>Inventors - Counts</li> <li>Age - Counts</li> <li>Words in document - Questel semantic count</li> <li>Words in abstract - Questel semantic count</li> <li>Words in description - Questel semantic count</li> <li>WO and EP designated states - Counts</li> <li>Drawings - Counts</li> <li>US specific - Counts</li> <li>Licensing agreements - Counts</li> <li>Number of figures</li> <li>WO parent</li> <li>Number of priorities</li> <li>Licensing interest names</li> <li>Security interest names</li> <li>Referenced drug names</li> <li>WO parent</li> <li>EP parent</li> <li>Filing notes</li> <li>Filing details</li> <li>Filing language</li> <li>Litigation</li> <li>Standards</li> <li>Licence ID</li> </ol> <p>The original format of the report generated by the database was preserved.</p> <p>In order to manage the query according to specific or joint interests, the PDF files are presented separately and also gathered in a single document (with 12,200 pages). This aggregated file is organized with the results of the world appearing in first place and those of the Ibero-American countries next, both obeying the numbering order of the prospected routes, separated by the respective summaries of contents.</p> <p> </p> <p><strong>References</strong></p> <p> </p> <p>Orbit. (2013). IP Business Intelligence (Gold and Platinum Versions). <em>Orbit Help Documents</em>.</p> <p>Orbit. (2015). Orbit Work Files. <em>Orbit Help Documents</em>.</p> <p>Orbit Intelligence. (2021). <em>FullPat: worldwide collection of patents containing bibliographic information, full text & legal status</em>.</p> <p>Orbit Intelligence. (2022). <em>Fampat: worldwide collection of patents grouped by invention-based families containing bibliographic information, full text & legal status</em>.</p> <p>Winson, A. (2013). <em>Industrial Designs in Orbit.com</em>. <em>April</em>, 1–5.</p>
References on routes of Policosanol extraction: a review from Scopus Elsevier (October 1, 2024)
<p>References on routes of Policosanol extraction: a review from Scopus Elsevier</p> <p><strong>SUMMARY</strong></p> <p><a href="#_Toc132834582">REFERENCES 01 – Policosanol in general 2</a></p> <p><a href="#_Toc132834583">REFERENCES 02 – All Routes: Saponification, Solvent extraction, Transesterification and molecular distillation, Supercritical carbon dioxide extraction, Ultrasonic-assisted extraction.. 14</a></p> <p><a href="#_Toc132834584">REFERENCES 03 – Saponification. 17</a></p> <p><a href="#_Toc132834585">REFERENCES 04 - Solvent extraction. 18</a></p> <p><a href="#_Toc132834586">REFERENCES 05 - Molecular distillation. 20</a></p> <p><a href="#_Toc132834587">REFERENCES 06 – Transesterification. 21</a></p> <p><a href="#_Toc132834588">REFERENCES 07 - Supercritical carbon dioxide extraction. 22</a></p> <p><a href="#_Toc132834589">REFERENCES 08 - Ultrasonic-assisted extraction. 24</a></p>
Long Term Efficacy and Tolerability of a Nutraceutical Combination (Red Yeast Rice, Policosanols and Berberine) in Low-moderate Risk Hypercholesterolemic Patients: a Double-blind, Placebo Controlled S
ClinicalTrials.gov study NCT02078167. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Effect of Policosanol as Monotherapy and Adjunctive to Statin Therapy
ClinicalTrials.gov study NCT00510809. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cholesterol-Lowering Effects of Policosanol
ClinicalTrials.gov study NCT00288483. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Preliminary Study of Safety and Efficacy of Policosanol
ClinicalTrials.gov study NCT00312923. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Policosanol extraction patents in six extraction routes from IP Business Intelligence of Orbit seekers (version 1.9.8)®: World and Ibero-American countries (CSV Format).
<p>These results include tables of contents in CSV format of patents, corresponding to the substance Policosanol and its six main extraction methods, in the world and in Ibero-American countries, prospected from Advanced Search and IP Business Intelligence of Orbit seekers (version 1.9.8)<sup>® </sup>(Orbit, 2013, 2015; Orbit Intelligence, 2021, 2022; Winson, 2013).</p> <p>No results were found for the Ibero-American countries, in technological route 5 - "Molecular Distillation", until October 1, 2024, reason for the absence of their respective files in PDF and CSV.</p> <p>The prospecting reports contain the following information:</p> <ol> <li>Priority numbers</li> <li>Application number</li> <li>Publication numbers</li> <li>Family numbers</li> <li>Priority dates</li> <li>Application dates</li> <li>Publication dates</li> <li>Grant date</li> <li>Expected expiry dates</li> <li>Titles</li> <li>Abstracts</li> <li>Assignees</li> <li>Inventors</li> <li>Representatives</li> <li>Key content</li> <li>Technical concepts</li> <li>Images</li> <li>Claims</li> <li>Description</li> <li>Keywords in context</li> <li>Technology domains</li> <li>Cooperative classification</li> <li>International classification</li> <li>US patent classification</li> <li>Japanese classifications</li> <li>Citing patents (forward citations)</li> <li>Citing patents - Raw information</li> <li>Cited patents (backward citations)</li> <li>Cited patents - Raw information</li> <li>Cited non-patent literature</li> <li>Legal status</li> <li>Legal actions</li> <li>Designated states</li> <li>Protected authorities</li> <li>Farliest countries</li> <li>Assignee country</li> <li>Representative country</li> <li>Inventor country</li> <li>Cited patents (backward citations) - Counts</li> <li>Citing patents (forward citations) - Counts</li> <li>Independent claims - Counts</li> <li>Dependent claims - Counts</li> <li>All claims - Counts</li> <li>Assignees - Counts</li> <li>Inventors - Counts</li> <li>Age - Counts</li> <li>Words in document - Questel semantic count</li> <li>Words in abstract - Questel semantic count</li> <li>Words in description - Questel semantic count</li> <li>WO and EP designated states - Counts</li> <li>Drawings - Counts</li> <li>US specific - Counts</li> <li>Licensing agreements - Counts</li> <li>Number of figures</li> <li>WO parent</li> <li>Number of priorities</li> <li>Licensing interest names</li> <li>Security interest names</li> <li>Referenced drug names</li> <li>WO parent</li> <li>EP parent</li> <li>Filing notes</li> <li>Filing details</li> <li>Filing language</li> <li>Litigation</li> <li>Standards</li> <li>Licence ID</li> </ol> <p>The original format of the report generated by the database was preserved.</p> <p>In order to manage the query according to specific or joint interests, the PDF files are presented separately and also gathered in a single document (with 12,200 pages). This aggregated file is organized with the results of the world appearing in first place and those of the Ibero-American countries next, both obeying the numbering order of the prospected routes, separated by the respective summaries of contents.</p>
Databases Merged of "Cross Meta-Analysis on Policosanol Extraction": World and Ibero-American Countries
<p>These database derives from the processes of standardization, merge and removing duplication of results found in the Scopus Elsevier and Web of Science bases, in CSV format to be used with software suitable for replicating the results, new statistical, bibliometric, semantic and other treatments.</p> <p> </p> <p>Database1 (World): (Search No. - Route): 01 – PC in General</p> <p>Database3 (World): (Search No. - Route): 03 – Saponification extraction</p> <p>Database4 (World): (Search No. - Route): 04 - Solvent extraction</p> <p>Database5 (World): (Search No. - Route): 05 - Molecular distillation extraction</p> <p>Database6 (World): (Search No. - Route): 06 – Transesterification extraction</p> <p>Database7 (World): (Search No. - Route): 07 - Supercritical carbon dioxide extraction</p> <p>Database8 (World): (Search No. - Route): 08 - Ultrasonic-assisted extraction</p> <p>...</p> <p>Database1 - Ibero-American: (Search No. - Route): 01 – PC in General</p> <p>Database3 - Ibero-American: (Search No. - Route): 03 – Saponification extraction</p> <p>Database4 - Ibero-American: (Search No. - Route): 04 - Solvent extraction</p> <p>No data - Database5 - Ibero-American: (Search No. - Route): 05 - Molecular distillation extraction </p> <p>No data - Database6 - Ibero-American: (Search No. - Route): 06 – Transesterification extraction</p> <p>Database7 - Ibero-American: (Search No. - Route): 07 - Supercritical carbon dioxide extraction</p> <p>Database8 - Ibero-American: (Search No. - Route): 08 - Ultrasonic-assisted extraction</p>
Study of Policosanol to Improve Platelet Reactivity After Percutaneous Coronary Stent Implantation (PCI)
ClinicalTrials.gov study NCT01371058. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Policosanol for the Treatment of Hypercholesterolemia
ClinicalTrials.gov study NCT00255216. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of Fermented Milk Product Enriched With Plant Sterols and Policosanols in Mild Hypercholesterolaemic Adults
ClinicalTrials.gov study NCT01571882. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Main areas of research and scientific production regionalized by Policosanol biorefining route: from the 1990s to the 2024 (October 1, 2024).
<p>The Table 1 presents the results of surveys, in 18 Ibero-American countries and in the world, carried out in the Science Citation Index Expanded (SCI-E) or Web of Science - Core Collection - Clarivate Analytics – (WoS) and Scopus (Elsevier): AR - Argentina, BR - Brazil, CL - Chile, CO - Colombia, CR - Cota Rica, CU - Cuba, DO - Dominican Republic, EC - Ecuador, ES - Spain, GT - Guatemala, HN - Honduras, MX - Mexico, NI - Nicaragua, PA - Panama, PE - Peru, PT - Portugal, SV - El Salvador, UY - Uruguay. </p> <p>Merging the Scopus and Web of Science bases, the scientometric methodology of K-Synth (Bibliometrix) is applied here, according to which the scientific production of each country is measured by the number of appearances of authors by country affiliations. Thus, if in an article there are, for example, three authors working, respectively, in Brazil, Spain and the USA, the appearance counter will be increased by 1 for each of them. Due to the identification of some gaps, the electronically merged data were reconciled with the original databases.</p> <p>As for the Main Subject Areas, the classification adopted is that of Scopus Elsevier, as well as the compiled data, as it is the most quantitatively complete basis for this research. </p> <p>Data is updated until October 1, 2024.</p>
Databases of "Economic criteria of Policosanol extraction" article: standardization, merge and removing duplication of results found in the Scopus Elsevier and Web of Science bases
<p>These eight databases derives from the processes of standardization, merge and removing duplication of results found in the Scopus Elsevier and Web of Science bases, in CSV format to be used with software suitable for replicating the results, new statistical, bibliometric, semantic and other treatments.</p> <p>DatabaseE1 - Extraction - BUSINESS ATTRACTIVENESS. </p> <p>DatabaseE2 - Extraction - COMMERCIAL AND EXPORT FEASIBILITY </p> <p>DatabaseE3 - Extraction - TECHNICAL AND INDUSTRIAL VIABILITY: </p> <p>DatabaseE4 - Extraction - ECOEFICIENCY</p> <p>DatabaseEG1 - General - BUSINESS ATTRACTIVENESS </p> <p>DatabaseEG2 - General - COMMERCIAL AND EXPORT FEASIBILITY </p> <p>DatabaseEG3 - General - TECHNICAL AND INDUSTRIAL VIABILITY: </p> <p>DatabaseEG4 - General - ECOEFICIENCY</p> <p>It is constitutive of the article entitled " Economic criteria of Policosanol extraction: a systematic literature review and patent prospection", by professors Rilton Gonçalo Bonfim Primo, Jesus Martín-Gil, Fernando Cardoso Pedrão, Carlos Narciso Bouza and Ricardo de Araújo Kalid.</p>
Databases of Patent Prospection of "Economic criteria on Policosanol extraction" study: CSV and PDF documents
<p>These databases derive from the processes of patent prospection on Economic Criteria in Patents on Policosanol by Advanced Search and IP Business Intelligence of Orbit seekers (version 1.9.8), in CSV format to be used with software suitable for replicating the results, new statistical, semantic and other treatments.</p> <p>They are doubted in two groups: 1) economic criteria referred to in patents on Policosanol, in a broad way, involving processes before or after obtaining them (mode FamPat); 2) economic criteria mentioned in patents on Policosanol, specifically involving its extraction processes (mode FullPat).</p> <p>No results were found, for extraction modality, in searches 03 for Ibero-American countries and 04, so the corresponding databases were not generated.</p> <p>Three PDF achieves with the first page of the patents/family and its technical links are available for easy consults of main information. </p> <p>These elements are constitutive of the article entitled "Economic criteria on Policosanol extraction: a systematic literature review and patents prospection", by professors Rilton Gonçalo Bonfim Primo, Jesus Martín-Gil, Fernando Cardoso Pedrão, Carlos Narciso Bouza and Ricardo de Araújo Kalid.</p>
Technical report with partial results of the article "Technological routes of Policosanols extraction"
<p>It is constitutive of the article entitled "Technological routes of Policosanols extraction: a systematic literature review and patent prospection", by professors Rilton Gonçalo Bonfim Primo, Jesus Martín-Gil, Fernando Cardoso Pedrão, Carlos Narciso Bouza and Ricardo de Araújo Kalid.</p> <p>In the Table 1, Table 2 and Table 3 one care taken was to carry out the “Extended Search” (i.e., in all fields of the articles, not just in the title, abstract and keywords) in cases where the results were less than ten. This inclusiveness naturally implies refiltering articles outside the scope of the research. Policosanol spelling variants, with "y" or "i", and suffix variations “ultrasonic” or “ultrasound” were considered in these searches.</p> <p>Methodological, computational and bibliometric aspects, as well as their historical, research, discussions and inferences contexts can be found in the referred article, of which this document is only a data repository of leading partial results, through quantitative and qualitative analyzes, to the final results achieved there.</p>
Databases of Patent Prospection of "Cross Meta-Analysis on Policosanol Extraction": CSV documents
<p>These eight database derives from the processes of patent prospection (mode FullPat) on Policosanol Extraction routes by Advanced Search and IP Business Intelligence of Orbit seekers (version 1.9.8), in CSV format to be used with software suitable for replicating the results, new statistical, semantic and other treatments:</p> <p><a href="https://zenodo.org/api/files/f1338222-8669-4162-8a84-0a42012bff2c/Policosanol%20Extraction%201%20-%20PC.csv">Policosanol Extraction 1 - PC.csv </a><br> md5:28570b475b35de6c65731d46a281a1cf 13.6 Mb<br> <br> <a href="https://zenodo.org/api/files/f1338222-8669-4162-8a84-0a42012bff2c/Policosanol%20Extraction%202%20-%20Main%20Six%20Routes.csv">Policosanol Extraction 2 - Main Six Routes.csv </a><br> md5:6b353e6f7520143fe3b871adb73fc0a1 13 Mb<br> <br> <a href="https://zenodo.org/api/files/f1338222-8669-4162-8a84-0a42012bff2c/Policosanol%20Extraction%203%20-%20Saponification.csv">Policosanol Extraction 3 - Saponification.csv </a><br> md5:7df07dc0f7972daee164bd11e8ec73b4 2.6 Mb<br> <br> <a href="https://zenodo.org/api/files/f1338222-8669-4162-8a84-0a42012bff2c/Policosanol%20Extraction%204%20-%20Solvent.csv">Policosanol Extraction 4 - Solvent.csv </a><br> md5:234d24518517d0dcba2fbdbe32a347f9 25.9 Mb<br> <br> <a href="https://zenodo.org/api/files/f1338222-8669-4162-8a84-0a42012bff2c/Policosanol%20Extraction%205%20-%20Molecular%20distillation.csv">Policosanol Extraction 5 - Molecular distillation. ...</a><br> md5:fd92dc4172aee67dc998cd93f20b5f37 433 Kb<br> <br> <a href="https://zenodo.org/api/files/f1338222-8669-4162-8a84-0a42012bff2c/Policosanol%20Extraction%206%20-%20Transesterification.csv">Policosanol Extraction 6 - Transesterification.csv </a><br> md5:9d872ba0f16372d4c5b6755b043789ea 178 Kb<br> <br> <a href="https://zenodo.org/api/files/f1338222-8669-4162-8a84-0a42012bff2c/Policosanol%20Extraction%207%20-%20Supercritical.csv">Policosanol Extraction 7 - Supercritical.csv </a><br> md5:223dae0b3b88f4fd01c7957ea8525874 21.5 Mb<br> <br> <a href="https://zenodo.org/api/files/f1338222-8669-4162-8a84-0a42012bff2c/Policosanol%20Extraction%208%20-%20Ultrasonic.csv">Policosanol Extraction 8 - Ultrasonic.csv </a><br> md5:45a64314dd8420ec955136515fe48192</p> <p>These prospects through Orbit were updated in May 16, 2023, without presenting relevant changes. </p> <p>These elements are constitutive of the article entitled "Cross Meta-Analysis on Policosanol Extraction", by PRIMO, R. et al.</p>
Main areas of research and scientific production regionalized by Policosanol biorefining route: from the 1990s to the 2024 (June).
<p><span>The Table 1 presents the results of surveys, in 18 Ibero-American countries and in the world, carried out in the Science Citation Index Expanded (SCI-E) or Web of Science - Core Collection - Clarivate Analytics – (WoS) and Scopus (Elsevier): </span><span>AR - Argentina, BR - Brazil, CL - Chile, CO - Colombia, CR - Cota Rica, CU - Cuba, DO - Dominican Republic, EC - Ecuador, ES - Spain, GT - Guatemala, HN - Honduras, MX - Mexico, NI - Nicaragua, PA - Panama, PE - Peru, PT - Portugal, SV - El Salvador, UY - Uruguay. </span></p> <p> </p> <p><span>Merging the Scopus and Web of Science bases, the scientometric methodology of K-Synth (Bibliometrix) is applied here, according to which the scientific production of each country is measured by the number of appearances of authors by country affiliations. Thus, if in an article there are, for example, three authors working, respectively, in Brazil, Spain and the USA, the appearance counter will be increased by 1 for each of them. Due to the identification of some gaps, the electronically merged data were reconciled with the original databases.</span></p> <p><span> </span></p> <p><span>As for the Main Subject Areas, the classification adopted is that of Scopus Elsevier, as well as the compiled data, as it is the most quantitatively complete basis for this research. </span></p> <p><span> </span></p> <p><span>Data is updated until June 2024.</span></p>
Main policosanol extraction patents.
<p>Main policosanol extraction patents (parameters and yields) by saponification, transesterification, solvent extraction, supercritical CO<sub>2</sub> extraction and ultrasonic extraction. </p> <p> </p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.